<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05053009</url>
  </required_header>
  <id_info>
    <org_study_id>ENDO3-7-1</org_study_id>
    <nct_id>NCT05053009</nct_id>
  </id_info>
  <brief_title>Effect of Ibuprofen Sustained Release on Intraoperative and Postoperative Pain in Mandibular Molars</brief_title>
  <official_title>The Effect of Ibuprofen Sustained Release Oral Premedication on Intraoperative and Postoperative Pain After Single-visit Root Canal Treatment of Mandibular Molars With Symptomatic Irreversible Pulpitis and Apical Periodontitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is conducted to evaluate the effect of Ibuprofen sustained release premedication on&#xD;
      the success of buccal infiltration anaesthesia, intaroperative pain and post operative pain&#xD;
      in mandibular molars with symptomatic irreversible pulpitis and apical periodontitis&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 2021</start_date>
  <completion_date type="Anticipated">October 2022</completion_date>
  <primary_completion_date type="Anticipated">October 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Parallel assignment</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
    <masking_description>Triple</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy of buccal infiltration anaesthesia measured using Visual analogue scale</measure>
    <time_frame>During root canal treatment procedures</time_frame>
    <description>intensity of pain during root canal treatment procedures is recorded by the patient using VAS where 0=no pain, 1-3=mild pain, 4-6=moderate pain and 7-10=severe pain</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intensity of intraoperative pain</measure>
    <time_frame>During root canal treatment procedures</time_frame>
    <description>intensity of pain during root canal treatment procedures is recorded by the patient using VAS where 0=no pain, 1-3=mild pain, 4-6=moderate pain and 7-10=severe pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain</measure>
    <time_frame>up to 48 hours after endodontic treatment</time_frame>
    <description>Intensity of pain felt after endodontic treatment recorded by the patient using VAS where 0=no pain, 1-3=mild pain, 4-6=moderate pain and 7-10=severe pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of needed analgesic tablets in case of intolerable pain</measure>
    <time_frame>up to 48 hours after endodontic treatment</time_frame>
    <description>The patient will record the number of analgesic tablets taken in case of intolerable pain</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">48</enrollment>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>Ibuprofen sustained release</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single dose of 800 mg Brufen Retard oral premedication will be administered 1 hour before local anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>1 capsule of 500 mg of glucose oral premedication will be adminstered 1 hour before local anesthesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Brufen Retard</intervention_name>
    <description>800 mg tablet of Brufen Retard will be adminstered orally one hour before local anesthesia</description>
    <arm_group_label>Ibuprofen sustained release</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Systemically healthy patients (ASA I or II).&#xD;
&#xD;
          2. Patients with Mandibular molar teeth diagnosed with:&#xD;
&#xD;
               -  Pre-operative sharp pain marked on VAS scale by reading not less than 6.&#xD;
&#xD;
               -  Vital exaggerated response of pulp tissue to cold pulp tester (ethyl chloride&#xD;
                  spray) and electric pulp tester.&#xD;
&#xD;
               -  Normal periapical radiographic appearance or slight widening in lamina dura.&#xD;
&#xD;
               -  Positive response and pain provoked by percussion.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Allergy to Ibuprofen&#xD;
&#xD;
          2. Medically compromised patients having significant systemic disorders. (ASA III or IV).&#xD;
&#xD;
          3. History of intolerance to NSAIDS.&#xD;
&#xD;
          4. Patients with two or more adjacent teeth requiring endodontic treatment.&#xD;
&#xD;
          5. Pregnant or nursing females.&#xD;
&#xD;
          6. Teeth that have:&#xD;
&#xD;
               -  Periodontal affection (with pocket depth greater than 5mm, associated with&#xD;
                  swelling or fistulous tract, or greater than grade I mobility)&#xD;
&#xD;
               -  No possible restorability.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Mariam Ah Hossam, B.D.S</last_name>
    <phone>01110913251</phone>
    <phone_ext>002</phone_ext>
    <email>mariam.ahmed.hosam@dentistry.cu.edu.eg</email>
  </overall_contact>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 11, 2021</study_first_submitted>
  <study_first_submitted_qc>September 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 22, 2021</study_first_posted>
  <last_update_submitted>September 21, 2021</last_update_submitted>
  <last_update_submitted_qc>September 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Mariam Ahmed Hossam</investigator_full_name>
    <investigator_title>Resident at faculty of dentistry, Cairo University</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ibuprofen</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

